Eli Lilly, the makers of Zepbound, gained FDA approval for its drug orforglipron, sold under the brand name Foundayo, on April 1, 2026, following Novo Nordisk, which received approval for the Wegovy pill in December 2025
Together, our findings demonstrated GPR146 as a key regulator of inter-organ metabolic communication and a potential therapeutic target for obesity and MASLD
The expansion of Enterococcaceae may partly reflect radiation-associated intestinal dysbiosis, and its detection during radiotherapy could help capture clinically relevant fluctuations in microbial burden and community structures 71,134
Users with existing oral health conditions If you already have gum disease, active cavities, or other oral health conditions before starting a GLP-1 medication, address these issues first
K.SilversteinM.ChelmowD.CokerT